跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
FUPASCIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Approved
THERAPEUTIC
FUPASCIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Gland Pharma Ltd.
🇸🇬 Health Sciences Authority
Approval Date
May 14, 2019
Approval ID
732378c2df1de2c3
Company
Gland Pharma Ltd.
Type
Therapeutic
Approval Details
Approval Id
732378c2df1de2c3
Drug Name
FUPASCIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Product Name
FUPASCIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL
Approval Number
SIN15687P
Approval Date
2019-05-14
Registrant
PHARMAKOE PTE. LTD.
Licence Holder
PHARMAKOE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J02AX04
Atc Item Name
caspofungin
Pharma Manufacturer Name
PHARMAKOE PTE. LTD.
Company Detail Path
/organization/pharmakoe-pte-ltd
Active Ingredients
Caspofungin acetate 55.49mg equivalent to Caspofungin
50mg/vial
CASPOFUNGIN ACETATE 55.49 MG EQUIVALENT TO CASPOFUNGIN
50 MG/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 14, 2019
Approval ID
732378c2df1de2c3
Type
Therapeutic
Back to HSA Approvals
FUPASCIN POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL - HSA Drug Approval Details
